Press Releases



Mediclinic Intnl plc - Director/PDMR Shareholding

05/06/2018
RNS Number : 3469Q
Mediclinic International plc
05 June 2018
 

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC

JSE Share Code: MEI
NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

("Mediclinic", the "Company" or the "Group")

 

5 June 2018

 

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

Vesting of awards under the Company's Forfeitable Share Plan

 

Awards of ordinary shares in Mediclinic (the "Shares") under the Mediclinic International Limited Forfeitable Share Plan ("FSP") granted in June 2015 vested on 1 June 2018.

 

The table below sets out the number of shares vested for Directors and other persons discharging managerial responsibilities ("PDMRs") who were granted awards under the scheme, together with any disposals made to satisfy their tax liabilities arising on vesting or for other reasons. Mr Danie Meintjes sold the minimum number of shares required to satisfy any tax liability arising on vesting. All shares were sold at a price of ZAR106.91 per Share.

 

 

Name

 

Director/ PDMR

Number of JSE Shares vested

Number of Shares sold

Number of Shares retained

Danie Meintjes

Director

33 949

15 786

18 163

David Hadley

PDMR

7 185

7 185

0

Gert Hattingh

PDMR

10 094

4,693

5 401

Koert Pretorius

PDMR

13 241

13 241

0

Dr Dirk le Roux

PDMR

5 828

5 828

0

Dr Ole Wiesinger1

PDMR

12 156

n/a

n/a

 

Notes:

1.     Dr Wiesinger was granted a conditional right to 12 156 Shares under the Country Schedule to the Forfeitable Share Plan in June 2015, receivable in cash or Shares on vesting, at Dr Wiesinger's option. On 1 June 2018, Dr Wiesinger elected to receive the equivalent value of the vested shares in cash.

 

The performance conditions for awards made under the FSP were tested following the change of control in Mediclinic International Limited, resulting from its reverse takeover of Al Noor Hospitals Group Plc. The corresponding awards vested on the original vesting date.

 

The notifications below are made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation.

 


 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

 

a)

Name

Daniël Petrus Meintjes

 

2.

Reason for the notification

 

a)

Position / status

Executive Director of the Company

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of award over ordinary shares granted under the Company's Forfeitable Share Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Nil cost

33 949

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

33 949

 

Nil cost

 

e)

Date of the transaction

1 June 2018

 

f)

Place of the transaction

Johannesburg Stock Exchange

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Sale of shares vested under the Company's Forfeitable Share Plan to cover tax liabilities arising on vesting

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

ZAR 106.91

15 786

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

15 786

 

ZAR 106.91

 

e)

Date of the transaction

1 June 2018

 

f)

Place of the transaction

Johannesburg Stock Exchange

 

 


 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

 

a)

Name

David John Hadley

 

2.

Reason for the notification

 

a)

Position / status

Chief Executive Officer - Mediclinic Middle East

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of award over ordinary shares granted under the Company's Forfeitable Share Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Nil cost

7 185

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

7 185

 

Nil cost

 

e)

Date of the transaction

1 June 2018

 

f)

Place of the transaction

Johannesburg Stock Exchange

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Sale of shares vested under the Company's Forfeitable Share Plan

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

ZAR 106.91

7 185

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

7 185

 

ZAR 106.91

 

e)

Date of the transaction

1 June 2018

 

f)

Place of the transaction

Johannesburg Stock Exchange

 

 


 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

 

a)

Name

Gert Cornelis Hattingh

 

2.

Reason for the notification

 

a)

Position / status

Chief Corporate Services Officer of the Mediclinic Group

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of award over ordinary shares granted under the Company's Forfeitable Share Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Nil cost

10 094

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

10 094

 

Nil cost

 

e)

Date of the transaction

1 June 2018

 

f)

Place of the transaction

Johannesburg Stock Exchange

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Sale of shares vested under the Company's Forfeitable Share Plan to cover tax liabilities arising on vesting

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

ZAR 106.91

4 693

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

4 693

 

ZAR 106.91

 

e)

Date of the transaction

1 June 2018

 

f)

Place of the transaction

Johannesburg Stock Exchange

 

 


 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

 

a)

Name

Koert Hendrik Stefanus Pretorius

 

2.

Reason for the notification

 

a)

Position / status

Chief Executive Officer - Mediclinic Southern Africa

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of award over ordinary shares granted under the Company's Forfeitable Share Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Nil cost

13 241

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

13 241

 

ZAR 106.91

 

e)

Date of the transaction

1 June 2018

 

f)

Place of the transaction

Johannesburg Stock Exchange

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Sale of shares vested under the Company's Forfeitable Share Plan

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

ZAR 106.91

13 241

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

13 241

 

ZAR 106.91

 

e)

Date of the transaction

1 June 2018

 

f)

Place of the transaction

Johannesburg Stock Exchange

 

 


 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

 

a)

Name

Dr Dirk Cornelius le Roux

 

2.

Reason for the notification

 

a)

Position / status

Chief Information Officer of the Mediclinic Group

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of award over ordinary shares granted under the Company's Forfeitable Share Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Nil cost

5 828

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

5 828

 

Nil cost

 

e)

Date of the transaction

1 June 2018

 

f)

Place of the transaction

Johannesburg Stock Exchange

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Sale of shares vested under the Company's Forfeitable Share Plan

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

ZAR 106.91

5 828

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

5 828

 

ZAR 106.91

 

e)

Date of the transaction

1 June 2018

 

f)

Place of the transaction

Johannesburg Stock Exchange

 

 


 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

 

a)

Name

Dr Thorsten Ole Wiesinger

 

2.

Reason for the notification

 

a)

Position / status

Chief Executive Officer - Hirslanden

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of award over ordinary shares granted under the Company's Forfeitable Share Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Nil cost

12 156

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

12 156

 

Nil cost

 

e)

Date of the transaction

1 June 2018

 

f)

Place of the transaction

Johannesburg Stock Exchange

 

 


 

 

About Mediclinic International plc

 

Mediclinic is an international private healthcare services group with operating divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, an LSE-listed and UK-based private healthcare group.

 

Mediclinic comprises 75 hospitals and 28 clinics. Hirslanden operates 17 private acute care facilities and 4 clinics in Switzerland with more than 1 800 inpatient beds; Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 100 inpatient beds in total; and Mediclinic Middle East operates 6 hospitals and 22 clinics with more than 700 inpatient beds in the United Arab Emirates.

 

Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia.

 

For further information, please contact:

  Company Secretary, Link Company Matters Limited

Jayne Meacham / Caroline Emmet

+44 (0)20 7954 9569

 

Investor Relations, Mediclinic International plc

James Arnold, Head of Investor Relations

ir@mediclinic.com

+44 (0)20 3786 8181

 

Media queries

FTI Consulting

Brett Pollard/Debbie Scott - UK

+44 (0)20 3727 1000

Sherryn Schooling - South Africa

+27 (0)21 487 9000

 

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom

Website: www.mediclinic.com

Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGCGDLSUGBGIU